Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helen Krontiras

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Racial and Ethnic Health Disparities|September 5, 2024
Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer ClinicJillian Tinglin, M Chandler McLeod, Courtney P Williams, et al.
Annals of Surgical Oncology|May 3, 2014
Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)Elizabeth L Cureton, Christina Yau, Michael D Alvarado, et al.
The Journal of Surgical Research|October 4, 2018
Treatment patterns for ductal carcinoma in situ with close or positive mastectomy marginsCaroline E Jones, Joshua Richman, Bradford E Jackson, et al.
Southern Medical Journal|November 3, 2020
Less Toxic Chemotherapy in Locally Advanced Breast CancerJohn Carpenter, Andres Forero, Carla I Falkson, et al.
Frontiers in Oncology|July 26, 2022
Feasibility and Short-Term Toxicity of a Consecutively Delivered Five Fraction Stereotactic Body Radiation Therapy Regimen in Early-Stage Breast Cancer Patients Receiving Partial Breast IrradiationYilan Liu, Christopher Veale, Diana Hablitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteersJill M Kolesar, Ryan Hoel, Marcia Pomplun, et al.
BMJ Open|September 17, 2016
Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trialYuko Tsuruta, Laura Q Rogers, Helen Krontiras, et al.
BMJ Open|May 3, 2024
<u>Ro</u>le of Gut <u>M</u>icrobe Composition in Psychosocial Symptom Response to <u>E</u>xercise Training in Breast Cancer Survivors (ROME) study: protocol for a randomised controlled trialRebecca B Little, Stephen J Carter, Robert W Motl, et al.
Journal of Medicinal Chemistry|September 3, 2015
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary CancersVenkatram R Atigadda, Gang Xia, Anil Deshpande, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Racial and Ethnic Health Disparities|September 5, 2024
Impact of Affordable Care Act Provisions on the Racial Makeup of Patients Enrolled at a Deep South, High-Risk Breast Cancer ClinicJillian Tinglin, M Chandler McLeod, Courtney P Williams, et al.
Annals of Surgical Oncology|May 3, 2014
Local recurrence rates are low in high-risk neoadjuvant breast cancer in the I-SPY 1 Trial (CALGB 150007/150012; ACRIN 6657)Elizabeth L Cureton, Christina Yau, Michael D Alvarado, et al.
The Journal of Surgical Research|October 4, 2018
Treatment patterns for ductal carcinoma in situ with close or positive mastectomy marginsCaroline E Jones, Joshua Richman, Bradford E Jackson, et al.
Southern Medical Journal|November 3, 2020
Less Toxic Chemotherapy in Locally Advanced Breast CancerJohn Carpenter, Andres Forero, Carla I Falkson, et al.
Frontiers in Oncology|July 26, 2022
Feasibility and Short-Term Toxicity of a Consecutively Delivered Five Fraction Stereotactic Body Radiation Therapy Regimen in Early-Stage Breast Cancer Patients Receiving Partial Breast IrradiationYilan Liu, Christopher Veale, Diana Hablitz, et al.
Cancer Prevention Research (Philadelphia, Pa.)|December 15, 2010
A pilot, first-in-human, pharmacokinetic study of 9cUAB30 in healthy volunteersJill M Kolesar, Ryan Hoel, Marcia Pomplun, et al.
BMJ Open|September 17, 2016
Exploring effects of presurgical weight loss among women with stage 0-II breast cancer: protocol for a randomised controlled feasibility trialYuko Tsuruta, Laura Q Rogers, Helen Krontiras, et al.
BMJ Open|May 3, 2024
<u>Ro</u>le of Gut <u>M</u>icrobe Composition in Psychosocial Symptom Response to <u>E</u>xercise Training in Breast Cancer Survivors (ROME) study: protocol for a randomised controlled trialRebecca B Little, Stephen J Carter, Robert W Motl, et al.
Journal of Medicinal Chemistry|September 3, 2015
Conformationally Defined Rexinoids and Their Efficacy in the Prevention of Mammary CancersVenkatram R Atigadda, Gang Xia, Anil Deshpande, et al.
Breast Cancer Research and Treatment|July 29, 2011
Locally advanced breast cancers are more likely to present as Interval Cancers: results from the I-SPY 1 TRIAL (CALGB 150007/150012, ACRIN 6657, InterSPORE Trial)Cheryl Lin, Meredith Becker Buxton, Dan Moore, et al.
Pageof 6